BRPI0811387A2 - Método de administração de um surfactante pulmonar - Google Patents

Método de administração de um surfactante pulmonar

Info

Publication number
BRPI0811387A2
BRPI0811387A2 BRPI0811387-4A BRPI0811387A BRPI0811387A2 BR PI0811387 A2 BRPI0811387 A2 BR PI0811387A2 BR PI0811387 A BRPI0811387 A BR PI0811387A BR PI0811387 A2 BRPI0811387 A2 BR PI0811387A2
Authority
BR
Brazil
Prior art keywords
administration
pulmonary surfactant
pulmonary
surfactant
Prior art date
Application number
BRPI0811387-4A
Other languages
English (en)
Inventor
Egbert Herting
Wolfgang Gopel
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BRPI0811387A2 publication Critical patent/BRPI0811387A2/pt
Publication of BRPI0811387B1 publication Critical patent/BRPI0811387B1/pt
Publication of BRPI0811387B8 publication Critical patent/BRPI0811387B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0811387A 2007-06-08 2008-05-23 kit de administração de um surfactante pulmonar BRPI0811387B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/811,351 US8048043B2 (en) 2007-06-08 2007-06-08 Method of administration of a pulmonary surfactant
PCT/EP2008/004120 WO2008148469A1 (en) 2007-06-08 2008-05-23 A method of administration of a pulmonary surfactant

Publications (3)

Publication Number Publication Date
BRPI0811387A2 true BRPI0811387A2 (pt) 2015-07-21
BRPI0811387B1 BRPI0811387B1 (pt) 2018-11-06
BRPI0811387B8 BRPI0811387B8 (pt) 2021-05-25

Family

ID=39832595

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811387A BRPI0811387B8 (pt) 2007-06-08 2008-05-23 kit de administração de um surfactante pulmonar

Country Status (23)

Country Link
US (2) US8048043B2 (pt)
EP (2) EP2164504B1 (pt)
JP (1) JP5490683B2 (pt)
KR (2) KR101344159B1 (pt)
CN (1) CN101765431B (pt)
AU (1) AU2008258872B2 (pt)
BR (1) BRPI0811387B8 (pt)
CA (1) CA2690097C (pt)
CY (2) CY1116680T1 (pt)
DK (2) DK2164504T3 (pt)
EA (1) EA016308B1 (pt)
ES (2) ES2547489T3 (pt)
HK (1) HK1141457A1 (pt)
HR (2) HRP20150966T1 (pt)
HU (2) HUE025957T2 (pt)
LT (1) LT2719391T (pt)
ME (1) ME02327B (pt)
MX (2) MX359316B (pt)
PL (2) PL2164504T3 (pt)
PT (2) PT2719391T (pt)
RS (2) RS54196B1 (pt)
SI (2) SI2164504T1 (pt)
WO (1) WO2008148469A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475373B1 (en) * 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
RU2504395C1 (ru) * 2012-07-13 2014-01-20 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ/ФГБУ "РНЦРХТ" Минздравсоцразвития России Способ профилактики бронхолегочной дисплазии у новорожденных с очень низкой и экстремально низкой массой тела при рождении
ITMI20150033U1 (it) * 2015-02-13 2016-08-13 Chiesi Farm Spa Catetere per la somministrazione di un surfattante polmonare
EP3277351B1 (en) 2015-04-02 2019-06-05 Hill-Rom Services PTE. LTD. Manifold for respiratory device
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
WO2016174269A1 (en) * 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
MA46605A (fr) 2016-10-26 2021-06-02 Chiesi Farm Spa Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
JP2020502242A (ja) 2016-12-22 2020-01-23 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 進行性のｂｐｄの処置のための肺サーファクタント及びステロイドを含む処置的組み合わせ物
AU2019260526A1 (en) 2018-04-23 2020-11-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
MA54367A (fr) 2018-12-06 2021-11-10 Chiesi Farm Spa Dispositif de contrôle des voies aériennes à masque laryngé et procédé d'administration d'un médicament à travers un dispositif de contrôle des voies aériennes à masque laryngé
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
AU2022306466A1 (en) * 2021-07-05 2024-02-15 Chiesi Farmaceutici S.P.A. Process for the preparation of a pulmonary surfactant
CN115634199B (zh) * 2022-10-18 2024-05-03 杭州汉库医药科技有限公司 一种混悬型肺表面活性物质注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
GB9524007D0 (en) * 1995-11-23 1996-01-24 Bangham Alec D Endotrachael tubes with pulmonary medicaments
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
WO2003035679A2 (en) * 2001-10-25 2003-05-01 Medical Research Council Molecules
EP1897577B1 (de) * 2002-08-02 2012-05-16 Med In Medical Innovations GmbH Vorrichtung zur Erzeugung eines kontinuierlichen positiven Atemwegdrucks (CPAP-Vorrichtung)
US20060040860A1 (en) * 2004-06-17 2006-02-23 Mario Ruediger Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia
US20060112961A1 (en) * 2004-11-29 2006-06-01 Hany Aly Pediatric mask, especially suited for premature infants
ES2380046T3 (es) * 2005-01-06 2012-05-08 Discovery Laboratories, Inc. Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar

Also Published As

Publication number Publication date
EP2719391B1 (en) 2016-11-30
US20120017896A1 (en) 2012-01-26
KR101399738B1 (ko) 2014-05-27
AU2008258872B2 (en) 2012-10-04
KR101344159B1 (ko) 2013-12-23
HK1141457A1 (en) 2010-11-12
CN101765431B (zh) 2013-04-03
HRP20170270T1 (hr) 2017-04-21
KR20100028530A (ko) 2010-03-12
RS55733B1 (sr) 2017-07-31
US8905979B2 (en) 2014-12-09
US20080305180A1 (en) 2008-12-11
PL2719391T3 (pl) 2017-06-30
EP2164504A1 (en) 2010-03-24
MX359316B (es) 2018-09-25
RS54196B1 (en) 2015-12-31
CA2690097C (en) 2018-05-22
JP2010528729A (ja) 2010-08-26
BRPI0811387B8 (pt) 2021-05-25
EA016308B1 (ru) 2012-04-30
KR20130038940A (ko) 2013-04-18
ES2616727T3 (es) 2017-06-14
SI2164504T1 (sl) 2015-10-30
ME02327B (me) 2016-06-20
PT2164504E (pt) 2015-10-16
DK2164504T3 (en) 2015-10-12
HRP20150966T1 (hr) 2015-10-09
WO2008148469A1 (en) 2008-12-11
EA200901499A1 (ru) 2010-06-30
CA2690097A1 (en) 2008-12-11
HUE031750T2 (en) 2017-07-28
BRPI0811387B1 (pt) 2018-11-06
PT2719391T (pt) 2017-03-02
AU2008258872A1 (en) 2008-12-11
PL2164504T3 (pl) 2016-01-29
DK2719391T3 (en) 2017-02-20
SI2719391T1 (sl) 2017-03-31
JP5490683B2 (ja) 2014-05-14
MX2009012835A (es) 2009-12-15
US8048043B2 (en) 2011-11-01
ES2547489T3 (es) 2015-10-06
CN101765431A (zh) 2010-06-30
HUE025957T2 (en) 2016-05-30
EP2164504B1 (en) 2015-07-29
CY1116680T1 (el) 2017-03-15
CY1118635T1 (el) 2017-07-12
EP2719391A1 (en) 2014-04-16
LT2719391T (lt) 2017-02-10

Similar Documents

Publication Publication Date Title
BRPI0811387A2 (pt) Método de administração de um surfactante pulmonar
NO2020037I1 (no) alpelisib eller et farmasøytisk akseptabelt salt derav
NO2019024I1 (no) Brigatinib eller et farmasøytisk akseptabelt salt derav
NO2017059I1 (no) ribosiklib eller et farmasøytisk akseptabelt salt derav
NO2019010I1 (no) Eravasyklin eller farmasøytisk akseptable salter derav
NO2016014I2 (no) ceritinib eller farmasøytisk akseptable salter derav
NO2015014I1 (no) Paritaprevir, eller et farmasøytisk akseptabelt salt eller ester derav
BRPI0913021A2 (pt) distribuição pulmonar de uma fluoroquinolona
DK2186966T3 (da) Facadekonstruktion
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
DK2227126T3 (da) Sugedyse
BRPI0908116A2 (pt) pulverizador
DK2246336T3 (da) Fibroseinhibitor
ATE546453T1 (de) Nalmefen-hydrochlorid-dihydrat
BRPI0917179A2 (pt) turbina
DK2275414T3 (da) Cyclopentylacrylamidderivat
FI20065363A0 (fi) Erotusmenetelmä
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
FR2925543B1 (fr) Facade semi-rideau
BRPI0923233A2 (pt) combustor
BRPI0922853A2 (pt) combustor
NO2019009I1 (no) abemaciklib eller farmasøytisk akseptable salter derav
TH92788B (th) ของประดับตกแต่ง
EE00817U1 (et) Meetod ehitise valmistamiseks
FR2908437B1 (fr) Echafaudage

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B12F Other appeals [chapter 12.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/11/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/05/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF